FDA Takes Steps to Restrict 7-OH Opioid Products
The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal opioids by recommending a scheduling action to control certain 7-hydroxymitragynine (also known as 7-OH) products under the Controlled Substances Act (CSA). The FDA is specifically targeting 7-OH, a concentrated byproduct of the kratom plant; it is not […]
FDA Takes Steps to Restrict 7-OH Opioid Products Read More »